Showing results (21-30 of 108) with videos related to

Sort By:
Pageof 11
Cancer Science|April 1, 2020
In vitro and in vivo synergistic efficacy of ceritinib combined with programmed cell death ligand-1 inhibitor in anaplastic lymphoma kinase-rearranged non-small-cell lung cancerPing Du, Ting Hu, Zhuoling An, et al.
BMC Complementary and Alternative Medicine|August 5, 2014
Mechanism of curcumin resistance to human cytomegalovirus in HELF cellsYali Lv, Zhuoling An, Hui Chen, et al.
Clinical Therapeutics|December 17, 2024
Thrombotic Microangiopathy Associated with Calcineurin Inhibitors: A Real-World Analysis of Postmarketing Surveillance DataXin Yu, Yi Zhang, Zhuoling An, et al.
Journal of the American Pharmacists Association : Japha|March 21, 2026
Performance validation of large language models for drug-drug interaction consultations: Potential pharmacist assistant in outpatient pharmaceutical servicesHaoran Zhang, Anlin Wang, Cuiping He, et al.
Journal of Inflammation Research|March 25, 2026
FGF21 Exacerbates Obesity-Induced Airway Hyperresponsiveness and FGFR1-Dependent Mast Cell Activation in MiceLulu Ren, Lingling Xuan, Jie Zhang, et al.
Expert Review of Clinical Pharmacology|July 25, 2023
Phosphatidylinositol 3 kinase inhibitor-related pneumonitis: a systematic review and meta-analysisYi Zhang, Zhuo Ma, Yushu Wang, et al.
The Analyst|June 10, 2020
Simultaneous quantitative determination of arachidonic acid and cascade metabolites in rat serum by UPLC-MS/MS: application for longitudinal metabolomics of anlotinibPing Du, Ting Hu, Zhuoling An, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 15, 2021
Exploring the metabolic characteristics and pharmacokinetic variation of paroxetine in healthy volunteers using a pharmacometabonomic approachZhuoling An, Xiangyi Wang, Pengfei Li, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 1, 2023
Metabolomic analysis reveals the metabolic disturbance in aortic dissection: Subtype difference and accurate diagnosisJinghui Zhang, Lu Han, Hongchuan Liu, et al.
Cardiovascular Diabetology|November 20, 2025
Plasma metabolomics disentangles T2DM- and CAD-specific dysmetabolism and identifies potential biomarkers for CAD risk escalation in diabetic patientsTing Hu, Wen Zhang, Xian Ding, et al.
Pageof 11